Logo image of KEQU

KEWAUNEE SCIENTIFIC CP (KEQU) Stock Fundamental Analysis

USA - NASDAQ:KEQU - US4928541048 - Common Stock

40.5 USD
-1.12 (-2.69%)
Last: 11/12/2025, 8:00:02 PM
40.5 USD
0 (0%)
After Hours: 11/12/2025, 8:00:02 PM
Fundamental Rating

5

Taking everything into account, KEQU scores 5 out of 10 in our fundamental rating. KEQU was compared to 189 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of KEQU get a neutral evaluation. Nothing too spectacular is happening here. KEQU has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

KEQU had positive earnings in the past year.
In the past year KEQU had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: KEQU reported negative net income in multiple years.
In multiple years KEQU reported negative operating cash flow during the last 5 years.
KEQU Yearly Net Income VS EBIT VS OCF VS FCFKEQU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M 15M

1.2 Ratios

KEQU's Return On Assets of 6.36% is amongst the best of the industry. KEQU outperforms 85.19% of its industry peers.
KEQU has a better Return On Equity (18.34%) than 92.59% of its industry peers.
KEQU's Return On Invested Capital of 10.92% is amongst the best of the industry. KEQU outperforms 91.01% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for KEQU is in line with the industry average of 8.99%.
The last Return On Invested Capital (10.92%) for KEQU is above the 3 year average (9.90%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 6.36%
ROE 18.34%
ROIC 10.92%
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
KEQU Yearly ROA, ROE, ROICKEQU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

1.3 Margins

KEQU's Profit Margin of 4.68% is fine compared to the rest of the industry. KEQU outperforms 75.13% of its industry peers.
Looking at the Operating Margin, with a value of 7.60%, KEQU is in the better half of the industry, outperforming 74.60% of the companies in the same industry.
KEQU has a worse Gross Margin (29.37%) than 75.66% of its industry peers.
In the last couple of years the Gross Margin of KEQU has grown nicely.
Industry RankSector Rank
OM 7.6%
PM (TTM) 4.68%
GM 29.37%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
KEQU Yearly Profit, Operating, Gross MarginsKEQU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

6

2. Health

2.1 Basic Checks

KEQU has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
KEQU has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, KEQU has more shares outstanding
KEQU has a worse debt/assets ratio than last year.
KEQU Yearly Shares OutstandingKEQU Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500K 1M 1.5M 2M 2.5M
KEQU Yearly Total Debt VS Total AssetsKEQU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M

2.2 Solvency

An Altman-Z score of 3.13 indicates that KEQU is not in any danger for bankruptcy at the moment.
KEQU has a better Altman-Z score (3.13) than 71.43% of its industry peers.
The Debt to FCF ratio of KEQU is 3.45, which is a good value as it means it would take KEQU, 3.45 years of fcf income to pay off all of its debts.
KEQU has a Debt to FCF ratio of 3.45. This is amongst the best in the industry. KEQU outperforms 83.07% of its industry peers.
A Debt/Equity ratio of 0.91 indicates that KEQU is somewhat dependend on debt financing.
KEQU's Debt to Equity ratio of 0.91 is on the low side compared to the rest of the industry. KEQU is outperformed by 75.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 3.45
Altman-Z 3.13
ROIC/WACC1.4
WACC7.79%
KEQU Yearly LT Debt VS Equity VS FCFKEQU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M 60M

2.3 Liquidity

KEQU has a Current Ratio of 2.32. This indicates that KEQU is financially healthy and has no problem in meeting its short term obligations.
KEQU has a Current ratio (2.32) which is in line with its industry peers.
KEQU has a Quick Ratio of 1.63. This is a normal value and indicates that KEQU is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.63, KEQU is in line with its industry, outperforming 43.92% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.32
Quick Ratio 1.63
KEQU Yearly Current Assets VS Current LiabilitesKEQU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

3

3. Growth

3.1 Past

The earnings per share for KEQU have decreased strongly by -33.65% in the last year.
The Revenue has grown by 30.09% in the past year. This is a very strong growth!
Measured over the past years, KEQU shows a quite strong growth in Revenue. The Revenue has been growing by 10.27% on average per year.
EPS 1Y (TTM)-33.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.24%
Revenue 1Y (TTM)30.09%
Revenue growth 3Y12.5%
Revenue growth 5Y10.27%
Sales Q2Q%46.92%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
KEQU Yearly Revenue VS EstimatesKEQU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
KEQU Yearly EPS VS EstimatesKEQU Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 0.5 1 1.5

5

4. Valuation

4.1 Price/Earnings Ratio

KEQU is valuated reasonably with a Price/Earnings ratio of 9.78.
Based on the Price/Earnings ratio, KEQU is valued cheaper than 91.53% of the companies in the same industry.
When comparing the Price/Earnings ratio of KEQU to the average of the S&P500 Index (26.34), we can say KEQU is valued rather cheaply.
Industry RankSector Rank
PE 9.78
Fwd PE N/A
KEQU Price Earnings VS Forward Price EarningsKEQU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of KEQU indicates a rather cheap valuation: KEQU is cheaper than 96.30% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, KEQU is valued cheaply inside the industry as 98.41% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 6.21
EV/EBITDA 6.44
KEQU Per share dataKEQU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

KEQU has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

KEQU does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

KEWAUNEE SCIENTIFIC CP

NASDAQ:KEQU (11/12/2025, 8:00:02 PM)

After market: 40.5 0 (0%)

40.5

-1.12 (-2.69%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)09-10 2025-09-10/amc
Earnings (Next)12-09 2025-12-09
Inst Owners40.11%
Inst Owner Change-0.79%
Ins Owners16.53%
Ins Owner Change0.44%
Market Cap116.23M
Revenue(TTM)263.18M
Net Income(TTM)12.30M
Analysts82.86
Price TargetN/A
Short Float %2.2%
Short Ratio3.91
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 9.78
Fwd PE N/A
P/S 0.44
P/FCF 6.21
P/OCF 5.44
P/B 1.73
P/tB 3.13
EV/EBITDA 6.44
EPS(TTM)4.14
EY10.22%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)6.52
FCFY16.1%
OCF(TTM)7.45
OCFY18.38%
SpS91.7
BVpS23.37
TBVpS12.94
PEG (NY)N/A
PEG (5Y)N/A
Graham Number46.66
Profitability
Industry RankSector Rank
ROA 6.36%
ROE 18.34%
ROCE 13.98%
ROIC 10.92%
ROICexc 12.63%
ROICexgc 16.65%
OM 7.6%
PM (TTM) 4.68%
GM 29.37%
FCFM 7.11%
ROA(3y)6.79%
ROA(5y)2.22%
ROE(3y)17.94%
ROE(5y)5.55%
ROIC(3y)9.9%
ROIC(5y)N/A
ROICexc(3y)12.02%
ROICexc(5y)N/A
ROICexgc(3y)13.16%
ROICexgc(5y)N/A
ROCE(3y)12.97%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y25.96%
GM growth 5Y12.54%
F-Score4
Asset Turnover1.36
Health
Industry RankSector Rank
Debt/Equity 0.91
Debt/FCF 3.45
Debt/EBITDA 2.38
Cap/Depr 48.41%
Cap/Sales 1.01%
Interest Coverage 250
Cash Conversion 83.84%
Profit Quality 152.04%
Current Ratio 2.32
Quick Ratio 1.63
Altman-Z 3.13
F-Score4
WACC7.79%
ROIC/WACC1.4
Cap/Depr(3y)110.02%
Cap/Depr(5y)97.64%
Cap/Sales(3y)1.65%
Cap/Sales(5y)1.54%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%41.24%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)30.09%
Revenue growth 3Y12.5%
Revenue growth 5Y10.27%
Sales Q2Q%46.92%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y496.38%
FCF growth 3YN/A
FCF growth 5Y49.49%
OCF growth 1Y2996.81%
OCF growth 3YN/A
OCF growth 5Y28.86%

KEWAUNEE SCIENTIFIC CP / KEQU FAQ

What is the ChartMill fundamental rating of KEWAUNEE SCIENTIFIC CP (KEQU) stock?

ChartMill assigns a fundamental rating of 5 / 10 to KEQU.


Can you provide the valuation status for KEWAUNEE SCIENTIFIC CP?

ChartMill assigns a valuation rating of 5 / 10 to KEWAUNEE SCIENTIFIC CP (KEQU). This can be considered as Fairly Valued.


How profitable is KEWAUNEE SCIENTIFIC CP (KEQU) stock?

KEWAUNEE SCIENTIFIC CP (KEQU) has a profitability rating of 6 / 10.


Can you provide the dividend sustainability for KEQU stock?

The dividend rating of KEWAUNEE SCIENTIFIC CP (KEQU) is 0 / 10 and the dividend payout ratio is 0%.